Search company, investor...



Biz Plan Competition | Alive

Total Raised


Last Raised

$10K | 6 yrs ago

About Cellphmed

Cellphmed is a method developed by venturelab to verify the identity and quality of human cells.

Headquarters Location

IFJ Institut fur Jungunternehmen startup space Wiesenstrasse 5

Zurich, 8952,


+41 0712429888

Missing: Cellphmed's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cellphmed's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cellphmed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cellphmed is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Cellphmed News

Check out the four Venture Kick winners of stage 1

May 17, 2021

16.01.2017 These are the lucky winners of the latest first stage: Sleepiz, Lymphit, Skypull and Cellphmed. The four startups won CHF 10’000 each. They will soon compete on the second stage, where Venture Kick will allow them to expand their project and compete for another CHF 20'000 at the next stage. The team of Sleepiz The team of Cellphmed Sleepiz : Their product is a Multidimensional sleep monitoring and assessment device. Current state of the art sleep monitoring and assessment tools are unsuitable to carry out cost effective long term continuous patient monitoring and assessment. Their device is contactless, easy to use, inexpensive and robust in operation. Sleepiz combines state of the art sensor technologies and latest hardware with advanced learning algorithms to achieve clinical grade contact-less monitoring and assessment of sleep. The device does not demand specialized infrastructure for its operation. Dicronis : Lymphedema is a frequently occurring and serious complication of cancer therapies. It is a chronic and progressive disease, mostly outlined by the swelling of a limb, due to improper function of the lymphatic system. Lymphit helps to drastically improve its prognosis, by providing a diagnosis in the subclinical stage. The lymphatic function is assessed using a breakthrough microneedles-technology in a simple, safe, minimally-invasive, and cost-effective manner. Skypull : Their innovation is an airborne wind energy system, which consists of a fully autonomous flying device (drone) connected through a tether to an on-ground generator. The drone transforms the wind power available between 200 and 600 m above ground in traction on the cable, forcing the drum to unroll the tether from the generator to produce electricity. The duty cycle implies a generation phase (the flying device increases in altitude) and a recovery phase (losing altitude). The duty cycle is automatically and precisely managed by the control system on board the drone and the ground generation system. Cellphmed : The venture leaders alumnus developed a method to verify the identity and quality of human cells. With their disruptive technology Cellphmed is changing the process of drug development and will open doors for the advancement of personalized medicine. Based on Next Generation RNA Sequencing, their barcodes are a way to identify a cell based on its identity and state. Additional Links

Cellphmed Frequently Asked Questions (FAQ)

  • Where is Cellphmed's headquarters?

    Cellphmed's headquarters is located at IFJ Institut fur Jungunternehmen startup space, Zurich.

  • What is Cellphmed's latest funding round?

    Cellphmed's latest funding round is Biz Plan Competition.

  • How much did Cellphmed raise?

    Cellphmed raised a total of $10K.

  • Who are the investors of Cellphmed?

    Investors of Cellphmed include Venture Kick and MassChallenge.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.